Harry He
Chairman chez WUXI APPTEC CO., LTD.
Profil
Actuellement, Harry He occupe le poste de président du conseil de surveillance de WuXi AppTec Co. Ltd. et de président du conseil de surveillance de Shanghai Syn-the-all Pharmaceutical Co. Ltd. Dans sa carrière antérieure, M. He a été contact des relations avec les médias chez Wuxi PharmaTech (Cayman) Inc. Il a obtenu un diplôme de premier cycle à l'Université de technologie chimique de Beijing.
Postes actifs de Harry He
Sociétés | Poste | Début |
---|---|---|
WUXI APPTEC CO., LTD. | Chairman | 15/07/2016 |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Chairman | 02/11/2017 |
Anciens postes connus de Harry He
Sociétés | Poste | Fin |
---|---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | - |
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Public Communications Contact | - |
Formation de Harry He
Beijing University of Chemical Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
WUXI APPTEC CO., LTD. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Health Technology |